Revelation Biosciences, Inc. Common Stock (REVB)
Revelation Biosciences, Inc. Common Stock (REVB) has a 17-report earnings history dating back to May 17, 2022. Its average absolute post-earnings move is ±4.16%, and 47.1% of those reactions were positive. Its largest post-earnings gain was +25.15% (Nov 08, 2024) and its largest decline was -13.7% (May 10, 2024). The next earnings report is predicted for 2026-11-06 (approximate).
Earnings reactions
How REVB moved on each past earnings report.
Earnings Impact
Total Earnings
17
Avg Abs. Movement
±4.16%
Positive %
47.1%
Negative %
52.9%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 06, 2026 | ☽ POST | +2.27% | open_in_new |
| May 07, 2026 | ☽ POST | -0.5% | open_in_new |
| Feb 26, 2026 | ☽ POST | +0% | open_in_new |
| Nov 06, 2025 | ☽ POST | +0% | open_in_new |
Earnings Count
17
Total earnings in dataset
Avg Abs. Movement
±4.16%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260819 | open_in_new SEC.gov |
| 4 | 20260818 | open_in_new SEC.gov |
| 4 | 20260818 | open_in_new SEC.gov |
| 4 | 20260818 | open_in_new SEC.gov |
| 4 | 20260818 | open_in_new SEC.gov |
| 4 | 20260818 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| 10-Q | 20260806 | open_in_new SEC.gov |
| 8-K | 20260806 | open_in_new SEC.gov |
| 8-A12B | 20260713 | open_in_new SEC.gov |
Frequently asked about REVB earnings
When does Revelation Biosciences, Inc. Common Stock report earnings next? expand_more
Revelation Biosciences, Inc. Common Stock (REVB)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does REVB stock move after earnings? expand_more
Over 17 reports, REVB has moved an average of ±4.16% the session after earnings, closing higher 47.1% of the time.
What was REVB's biggest post-earnings move? expand_more
REVB's largest post-earnings gain on record was +25.15% on Nov 08, 2024, and its largest decline was -13.7% on May 10, 2024.
Where can I find Revelation Biosciences, Inc. Common Stock's SEC filings? expand_more
All of Revelation Biosciences, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right